IE
MIRA icon

Israel Englander’s MIRA Pharmaceuticals MIRA Stock Holding History

Israel Englander’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,725
Closed -$52.9K – 6249
2024
Q3 		$52.9K Buy
+40,725
New +$64.9K ﹤0.01% 5683

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Personalized Indexing Management
Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Israel Englander's MIRA Position: Q4 2024 in Review

Israel Englander sold out of MIRA Pharmaceuticals (MIRA) in Q4 2024, closing a stake of 40,725 shares — an estimated $52.9K sold.

Israel Englander first reported a position in MIRA in Q3 2024 and held it in 1 quarter. The position peaked at $52.9K in Q3 2024. 24 funds tracked by Wall St. Rank hold MIRA as of Q4 2024.

  • Israel Englander reported no remaining MIRA Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Israel Englander sold 40,725 MIRA Pharmaceuticals shares in Q4 2024, an estimated $52.9K.
  • Israel Englander first reported a position in MIRA Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Israel Englander's MIRA Pharmaceuticals position peaked at $52.9K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.